Healthcare Global Enterprises Q2 Results FY27: Revenue Up 13.13% to Rs 731.80 Cr, PAT Rs 4.79 Cr
- November 6, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Healthcare Global Enterprises Q2 Results FY27 were declared on 5 November 2026, and the quarterly results show consolidated revenue of Rs 731.80 Cr, up 13.13% YoY from Rs 646.85 Cr. Net profit came in at Rs 4.79 Cr, down 70.56% from Rs 16.27 Cr a year earlier, so YoY growth in revenue did not carry through to profit. These figures cover the July to September 2026 quarter.
Healthcare Global Enterprises Ltd (HCG) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The results date of 5 November 2026 brings consolidated results with revenue of Rs 731.80 Cr and PAT of Rs 4.79 Cr. Healthcare Global Enterprises Q2 Results FY27 therefore pair a 13.13% rise in revenue with a 70.56% fall in net profit on the same consolidated basis.
This Univest results analysis of Healthcare Global Enterprises Q2 Results covers the financial highlights, business drivers, outlook and risks for the quarter. The Financial Highlights table that follows sets the consolidated figures side by side before the narrative turns to what stands out.
Click Here – Get Free Investment Predictions
Healthcare Global Enterprises Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 731.8 Cr | Rs 646.85 Cr | +13.13% YoY |
| Net Profit (PAT) | Rs 4.79 Cr | Rs 16.27 Cr | -70.56% YoY |
Source: company filing for Healthcare Global Enterprises Q2 Results FY27, 5 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Healthcare Global Enterprises Q2 Results: What Stands Out
- Revenue: Consolidated revenue rose 13.13% YoY to Rs 731.80 Cr from Rs 646.85 Cr, and it was also up 5.3% from Rs 695.10 Cr in the previous quarter.
- Net profit: Net profit fell 70.56% YoY to Rs 4.79 Cr from Rs 16.27 Cr, so the YoY growth in revenue did not reach the bottom line.
- Profit margin: Net profit margin narrowed to 0.7% from 2.5% in the comparison quarter, as net profit fell while revenue rose.
- Reporting basis: Healthcare Global Enterprises Q2 Results FY27 are consolidated results for July to September 2026, declared on 5 November 2026.
- Return ratios: Return on equity was low at 2.04% and return on capital employed modest at 9.77% in FY26, which the performance analysis below puts in context.
Healthcare Global Enterprises Q2 Results FY27: Performance Analysis
The numbers show revenue rising while net profit fell sharply. Healthcare Global Enterprises reported consolidated revenue of Rs 731.80 Cr, up 13.13% YoY, against net profit of Rs 4.79 Cr, down 70.56% YoY. This results analysis therefore reads as growth in sales alongside a much smaller profit figure in the same quarter.
Revenue also moved up 5.3% from Rs 695.10 Cr in the previous quarter, which adds a sequential view to the YoY growth. Healthcare Global Enterprises Q2 Results FY27 thus show a higher revenue base than both the comparison quarter and the quarter before it, as the quarterly results confirm.
Net profit margin narrowed to 0.7% from 2.5% in the comparison quarter. That gap between revenue and profit makes Healthcare Global Enterprises Q2 Results a quarter in which the two lines moved in opposite directions. The supplied figures confirm what changed but do not establish the specific cause, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis points first to revenue, which grew 13.1% year on year to Rs 731.80 Cr in the latest quarter. This growth is the clearest business factor recorded in the quarterly results for Healthcare Global Enterprises Q2 Results FY27.
Sequential Revenue Gain – Revenue was up 5.3% quarter on quarter from Rs 695.10 Cr, which means the latest quarter also built on the first quarter of the year and not only on the comparison quarter a year earlier.
Profit Conversion – Net profit of Rs 4.79 Cr on revenue of Rs 731.80 Cr gives a net profit margin of 0.7%, compared with 2.5% a year earlier, so profit conversion was lower even as revenue rose.
FY27 Outlook After Healthcare Global Enterprises Q2 Results
FY27 full-year results will depend on the quarters that follow, and the quarter reported on 5 November 2026 is one input among several. Healthcare Global Enterprises Q2 Results FY27 supply revenue of Rs 731.80 Cr and net profit of Rs 4.79 Cr as reference points for that comparison.
Readers following this results analysis can compare each later quarter with these consolidated figures, including the 0.7% net profit margin, using the Univest Screener. Subsequent disclosures and sector conditions will shape how the FY27 numbers build up, and the risks below describe what the data flags for attention.
Key Risks to Watch After Healthcare Global Enterprises Q2 Results FY27
Net Profit Decline
Net profit fell 70.6% year on year to Rs 4.79 Cr, and that fall is the first risk flagged in the data. Healthcare Global Enterprises Q2 Results FY27 show it alongside revenue growth, so the gap between the two deserves attention.
Narrower Profit Margin
Net profit margin narrowed to 0.7% from 2.5% in the comparison quarter. A thinner margin means each rupee of revenue converted into less net profit, which investors can track through YoY growth in later quarterly figures.
Low Return on Equity
Return on equity was low at 2.04% in FY26, and return on capital employed was modest at 9.77% in the same year. These FY26 ratios sit behind the latest quarter and are worth tracking in later disclosures.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Healthcare Global Enterprises Q2 Results FY27 combine a 13.13% rise in revenue to Rs 731.80 Cr with a 70.56% fall in net profit to Rs 4.79 Cr. These consolidated results show higher sales and lower profit in the same quarter. For anyone tracking Healthcare Global Enterprises Q2 Results, the quarterly results are best read with the risks above, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Healthcare Global Enterprises Q2 Results FY27
What are Healthcare Global Enterprises Q2 Results FY27?
Ans. Healthcare Global Enterprises Q2 Results FY27 are the consolidated quarterly results for July to September 2026, showing revenue of Rs 731.80 Cr and net profit of Rs 4.79 Cr, as summarised in the Quick Answer at the top.
What is the results date for Healthcare Global Enterprises Q2 Results FY27?
Ans. The results date for Healthcare Global Enterprises Q2 Results FY27 is 5 November 2026, which means the figures cover the July to September 2026 quarter, as the opening paragraphs explain.
What revenue was reported in Healthcare Global Enterprises Q2 Results FY27?
Ans. Healthcare Global Enterprises reported consolidated revenue of Rs 731.80 Cr in the quarter, compared with Rs 646.85 Cr a year earlier, as shown in the Financial Highlights table above.
What net profit was reported in Healthcare Global Enterprises Q2 Results FY27?
Ans. Healthcare Global Enterprises reported net profit of Rs 4.79 Cr for the quarter, compared with Rs 16.27 Cr a year earlier, which the Performance Analysis section covers in more detail.
How much YoY growth did revenue show in Healthcare Global Enterprises Q2 Results FY27?
Ans. Revenue showed YoY growth of 13.13% in the quarter, while it was also up 5.3% from Rs 695.10 Cr in the previous quarter, as the Performance Analysis section explains.
Did net profit rise or fall in Healthcare Global Enterprises Q2 Results?
Ans. Net profit fell 70.56% YoY in the quarter, from Rs 16.27 Cr to Rs 4.79 Cr, while revenue rose, so the Key Takeaways section treats the two lines as moving in opposite directions.
What was the net profit margin in Healthcare Global Enterprises Q2 Results FY27?
Ans. Net profit margin was 0.7% in the quarter, against 2.5% in the comparison quarter, which means less of each rupee of revenue reached net profit, as the Key Business Factors section notes.
Are Healthcare Global Enterprises Q2 Results consolidated results or standalone results?
Ans. Healthcare Global Enterprises Q2 Results are consolidated results, which means the revenue of Rs 731.80 Cr and net profit of Rs 4.79 Cr cover the group on a consolidated basis, as the Conclusion also states.
What business factors shaped Healthcare Global Enterprises Q2 Results FY27?
Ans. Revenue growth of 13.1% year on year and a 5.3% rise from the previous quarter shaped the quarter, while the Key Business Factors section also covers how net profit converted from revenue.
What are the key risks after Healthcare Global Enterprises Q2 Results FY27?
Ans. The key risks are the 70.6% fall in net profit and the narrower 0.7% net profit margin, alongside a low return on equity of 2.04% in FY26, as listed in the Key Risks section.
What is the outlook after Healthcare Global Enterprises Q2 Results?
Ans. FY27 full-year results will depend on the quarters that follow, so revenue of Rs 731.80 Cr and net profit of Rs 4.79 Cr serve as the reference points listed in the Outlook section.
Where can I find the complete Healthcare Global Enterprises Q2 Results FY27 data?
Ans. The complete Healthcare Global Enterprises Q2 Results FY27 data sits in the Financial Highlights table above, while the Univest app lets investors follow later quarterly results for the stock alongside these consolidated figures.
